Everett Harris & Co’s Gilead Sciences GILD Stock Holding History

Everett Harris & Co’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$240K	Hold	1,902	–	–	﹤0.01%	271
2026 Q1	$265K	Hold	1,902	–	–	﹤0.01%	294
2025 Q4	$233K	Hold	1,902	–	–	﹤0.01%	302
2025 Q3	$211K	Sell	1,902 -125	-6%	-$14.2K	﹤0.01%	308
2025 Q2	$225K	Sell	2,027 -25	-1%	-$2.66K	﹤0.01%	309
2025 Q1	$230K	Buy	+2,052	New	+$212K	﹤0.01%	295
2024 Q1	–	Sell	-2,869	Closed	-$232K	–	274
2023 Q4	$232K	Sell	2,869 -25	-0.9%	-$1.95K	﹤0.01%	240
2023 Q3	$217K	Sell	2,894 -524	-15%	-$40.3K	﹤0.01%	238
2023 Q2	$263K	Buy	3,418 +39	+1%	+$3.11K	﹤0.01%	222
2023 Q1	$280K	Hold	3,379	–	–	﹤0.01%	219
2022 Q4	$290K	Buy	+3,379	New	+$268K	0.01%	215
2016 Q1	–	Sell	-1,986	Closed	-$201K	–	246
2015 Q4	$201K	Buy	+1,986	New	+$207K	0.01%	222
2015 Q3	–	Sell	-1,986	Closed	-$233K	–	240
2015 Q2	$233K	Buy	+1,986	New	+$217K	0.01%	214
2014 Q4	–	Sell	-2,086	Closed	-$222K	–	238
2014 Q3	$222K	Buy	+2,086	New	+$204K	0.01%	221

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Everett Harris & Co's GILD Position: Q2 2026 in Review

Everett Harris & Co held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,902 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #271.

Everett Harris & Co first reported a position in GILD in Q3 2014 and has held it in 14 quarters since. The position peaked at $290K in Q4 2022. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Everett Harris & Co held 1,902 shares of Gilead Sciences worth $240K as of Q2 2026.
Everett Harris & Co left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up ﹤0.01% of Everett Harris & Co's portfolio in Q2 2026, its #271 holding.
Everett Harris & Co first reported a position in Gilead Sciences in Q3 2014 and has held it in 14 quarters since.
Everett Harris & Co's Gilead Sciences position peaked at $290K in Q4 2022.
2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Everett Harris & Co's 13F filing for Q2 2026, filed 3 Aug 2026.